DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on November 16, 2004; DOI: 10.1124/dmd.104.001289


0090-9556/05/3302-282-286$20.00
DMD 33:282-286, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.104.001289v1
33/2/282    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanzlik, R. P.
Right arrow Articles by Eells, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanzlik, R. P.
Right arrow Articles by Eells, J. T.

ABSORPTION AND ELIMINATION OF FORMATE FOLLOWING ORAL ADMINISTRATION OF CALCIUM FORMATE IN FEMALE HUMAN SUBJECTS

Robert P. Hanzlik, Stephen C. Fowler, and Janis T. Eells

Departments of Medicinal Chemistry (R.P.H.) and Pharmacology and Toxicology (S.C.F.), University of Kansas, Lawrence, Kansas; and the Department of Health Sciences, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (J.T.E.)

Calcium formate is a water-soluble salt of an essential mineral nutrient with potential for use as a dietary calcium supplement. Formate ion is a product of endogenous and xenobiotic metabolism, but sustained high plasma formate concentrations (such as occur in cases of methanol poisoning) are toxic to the retina and optic nerve. Humans and primates have reduced capacity for formate oxidation compared with rodents and dogs and are thus more sensitive to methanol (and formate) intoxication. To assess the potential for accumulation of formate ion upon repeated administration of calcium formate as a potential dietary calcium supplement, we measured plasma concentrations of formate in 14 adult human subjects before and after oral administration of a single large dose of calcium formate (3900 mg; ca. 3–6 times the anticipated dose for calcium supplementation). Plasma formate concentrations increased briskly from 0.024 ± 0.008 mM (endogenous formate) to reach Cmax (0.50 ± 0.04 mM) at 60 min postdose and then declined with a half-life of 59 ± 7 min. By 225 min postdose, plasma formate concentration had returned to baseline. With such a short half-life, repeated use of calcium formate as a dietary supplement, even three times daily, should not lead to progressive accumulation of formate. These findings are discussed in light of the production of formate by endogenous and xenobiotic metabolism and the kinetics of formate during methanol poisoning.


Address correspondence to: Dr. Robert P. Hanzlik, University of Kansas, Department of Medicinal Chemistry, 1251 Wescoe Hall Drive, Room 4048 Malott, Lawrence, KS 66045-7582. E-mail: rhanzlik{at}ku.edu




This article has been cited by other articles:


Home page
J DAIRY SCIHome page
P. D. Constable, W. Grunberg, and L. Carstensen
Comparative effects of two oral rehydration solutions on milk clotting, abomasal luminal pH, and abomasal emptying rate in suckling calves
J Dairy Sci, January 1, 2009; 92(1): 296 - 312.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. Bosi, M. Mazzoni, S. De Filippi, P. Trevisi, L. Casini, G. Petrosino, and G. Lalatta-Costerbosa
A Continuous Dietary Supply of Free Calcium Formate Negatively Affects the Parietal Cell Population and Gastric RNA Expression for H+/K+-ATPase in Weaning Pigs
J. Nutr., May 1, 2006; 136(5): 1229 - 1235.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. P. Hanzlik, S. C. Fowler, and D. H. Fisher
Relative Bioavailability of Calcium from Calcium Formate, Calcium Citrate, and Calcium Carbonate
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1217 - 1222.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.